
Lupin shares in focus after exclusive deal with Chinese firm for diabetes, obesity management drug
The drug is a fortnightly, or once-in-two weeks, injectable GLP-1. It is indicated for Type 2 diabetes and weight management, Lupin stated in its exchange…








